期刊文献+

siRNA抑制人舌癌细胞VEGF表达对MMP-2、MMP-9及TIMP-1蛋白表达的影响 被引量:4

EFFECTS OF VEGF SUPPRESSION BY SIRNA ON THE EXPRESSION OF MMP-2,MMP-9 AND TIMP-1 IN HUMAN TONGUE SQUAMOUS CELL CAICINOMA
下载PDF
导出
摘要 目的:探讨小干扰RNA(small interfering RNA,siRNA)抑制人舌癌Tca8113细胞血管内皮生长因子(vascular endo-thelial growth factor,VEGF)表达对移植瘤基质金属蛋白酶(matrix metalloproteinases,MMP)-2、MMP-9及基质金属蛋白酶抑制剂-1(tissue inhibitors of metalloproteinase-1,TIMP-1)蛋白表达的影响。方法:以稳定转染携带针对VEGF的siRNA真核表达载体的人舌癌Tca8113细胞(VEGF-siRNA1、VEGF-siRNA2)为实验组,以转染空载体的人舌癌Tca8113细胞及未转染的人舌癌Tca8113细胞为实验对照组和空白对照组,将各组细胞分别接种于裸鼠皮下,用明胶酶谱实验及蛋白免疫印迹法分别测定各组移植瘤TIMP-2、TIMP-9及TIMP-1的蛋白表达。结果:各组明胶酶谱实验结果均有较明显MMP-9蛋白表达,活性MMP-9蛋白含量较少,MMP-2蛋白表达量明显少于MMP-9蛋白表达,而活性MMP-2几乎完全没有可见条带出现。各组中MMP-2、MMP-9及活性-MMP-9条带酶量差异均尚不具统计学意义(P>0.05)。以scion图像分析系统分别读取各样本TIMP-1条带灰度值及β-actin条带灰度值,各组中TIMP-1蛋白相对含量差异亦无统计学意义(P>0.05)。结论:以siRNA干扰人舌癌Tca8113细胞VEGF基因,可明显抑制肿瘤内VEGF的蛋白表达,但是对MMP-2、MMP-9及TIMP-1蛋白的表达无明显影响。 Objective: To investigate the effects of vascular endothelial growth factor (VEGF) suppression by vector-based small interfering RNA (siRNA) on the expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors of metalloproteinase-1 (TIMP-1) in human tongue squamous cell carcinoma (Tca8113) in vitro and in vivo. Methods: The eukaryotic expression vector was taken as an experimental control into human tongue squamous cell carcinoma cell lines (Tca8113). The non-transfected Tca8113 cells were used as negative control. The transfected cells and non-transfected cells were injected subcutaneously on the back of twenty nudemice which were divided into four groups randomly ( n = 5/group) ; re spectively. The expression of MMP-2, MMP-9 and TIMP-1 in xenograft tumors was detected by Gelatin zymography and Western blot protein immunoblotting. Results: Compared with the experimental and negative controls, the VEGF expression was decreased ( P 〈0.05) in two experimental groups of the xenograft tumors. There was no significant difference in the expression of MMP-2, MMP-9 and TIMP-1 among four groups of xenograft tumor ( P 〉0. 05). Conclusion: VEGF-siRNA can down-regulate the expression of VEGF in the human tongue squamous cell carcinoma in vitro and in vivo. However, it may not affect the expression of MMP-2, MMP-9 and TIMP-1 efficiently
出处 《广西医科大学学报》 CAS 2012年第4期493-495,共3页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No.30360111)
关键词 小干扰RNA 舌癌 血管内皮生长因子 基质金属蛋白酶 基质金属蛋白酶抑制剂 small interfering RNA(siRNA) vascularendothelial growth factor (VEGF) tongue squamouscell carcinoma matrix metalloproteinases (MMPS) tissue inhibitors of metalloproteinase (TIMPS)
  • 相关文献

参考文献7

  • 1Nelson AR,Fingieton B, Rothenberg ML, et al. Matrix metalloproteinase: biologic activity and clinical im-plication[J]. J Clin ()ncol.2000.18(5) : 1 135-1 149.
  • 2Riedel F,GotteK,SchwalbJ, et al. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma [J]. Int J Oncol, 2000,17 (6): 1 099-1 105.
  • 3Lamoreaux WJ , Fitzgerald Reiner A.et al. Vscular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metallo-proteinases by microvascular endothelial cells in vitro [J]. Microvasc Res,1998,55( 1):29-42.
  • 4于大海,郝洁,李敬,曹莹,陈海波.siRNA抑制人舌癌细胞VEGF表达对MMP-2、-9及TIMP-1、-2蛋白表达的影响[J].北京口腔医学,2010,18(1):1-4. 被引量:2
  • 5Hong X,Jiang F, Kalkanis SN, et al. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion[J]. J Exp T-her Oncol, 2007, 6(3) : 219-229.
  • 6Manenti L,Paganoni P,Floriani I, et al. Expression level of vascular endothelial growth factor, matrix met-alloproteinases 2 and 9 and tissue inhibitor of metallo-proteinases 1 and 2 in the plasma of patients with ovari-an carcinoma[J]. Eur J Cancer, 2003,39(13):1 948-1956.
  • 7于大海,曹莹,姚志文,李敬,陈海波,郝洁.载体携带小干扰RNA抑制Tca8113细胞血管内皮生长因子的表达[J].华西口腔医学杂志,2008,26(5):550-552. 被引量:4

二级参考文献15

  • 1Castro-Rivera E, Ran S, Thorpe P, et al. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect[J]. Proe Natl Aead Sci U S A, 2004, 101 (31) : 11432-11437.
  • 2Filleur S, Courtin A, Ait-Si-Ali S, et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth[J]. Cancer Res, 2003, 63(14):3919- 3922.
  • 3Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with hgand-targeted sterically stabilized nanoparticle[J]. Nucleic Acids Res, 2004, 32(19):E149.
  • 4Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics[J]. Cancer Res, 2004, 64(10):3365-3370.
  • 5Kwon HS, Shin HC, Kim JS. Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels[J]. Nucleic Acids Res, 2005, 33 (8):E74.
  • 6Zhang L, Yang N, Mohamed-Hadley A, et al. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer[J]. Biochem Biophys Res Commun, 2003, 303(4) : 1169-1178.
  • 7Wang FQ, So J, Reierstad S, et al. Vascular endothelial growth factorregulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases. Int J Cancer, 2006,118 (4) : 879-888.
  • 8Hong X, Jiang F, Kalkanis SN, et al. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion. J Exp Ther Oncol,2007,6(3) : 219-229.
  • 9Manenti L, Paganoni P, Floriani I, et al. Expression level of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer,2003,39(13) : 1948-1956.
  • 10Riedel F, G~tte K, Schwalb J, et aL Expression of 92-kDa type Ⅳ collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol,2000,17 (6) : 1099-1105.

共引文献4

同被引文献36

  • 1李冬梅,崔永兴,王立妍,董福生.唇癌微血管密度和血管内皮生长因子表达的意义[J].广东牙病防治,2004,12(4):246-248. 被引量:1
  • 2邹浩,张文峰,路彤彤,陈新明,赵怡芳.舌癌VEGF-C表达与颈淋巴结转移的关系及其临床意义[J].武汉大学学报(医学版),2005,26(1):80-82. 被引量:4
  • 3韩其滨,张文峰.203例舌癌患者复发相关因素分析[J].口腔医学研究,2005,21(3):321-323. 被引量:16
  • 4Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochan Biophys Res Commun, 1989, 161: 851-858.
  • 5Pepper MS, et al. Potent synergism between VEGE and bEGF in the induction of angiogenesis in vitro. Biochem Biophys Res Commun, 1992, 189: 824-831.
  • 6Bachelder RE, Crago A, Chung J, et al. Vascular endothelial growth factor is an autocrine survivalfactor tor neumpilinexpressing breast carcinoma cells. Cancer Res, 2001, 61( 12): 5736-5740.
  • 7Jackson MW, Roberts JS, Heckford SE, et al. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res, 2002, 62(3): 854-859.
  • 8de Vries C, escobedo JA, Ueno H, et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 1992, 255(5047): 989-991.
  • 9Fong GH, Rossant J, Gertsenstein M, et al. Role of the Fh- 1 receptor tyrosine kinase in regulating the assembly of vaschlar endothelium. Nature, 1995, 376(6535): 66-70.
  • 10Shalaby F, Rossant J, Yamaquchi TP, et al. Failure ofblood-island formation and vasculogenes is in Flk-l-deficient mice. Nature, 1995, 376(6535): 62-66.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部